Tarsus Pharmaceuticals, Inc.
TARS
$59.10
-$0.73-1.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.70% | 43.21% | 26.78% | 17.79% | 36.64% |
| Total Receivables | 82.70% | 81.25% | 145.30% | 95.32% | 104.56% |
| Inventory | 69.02% | 66.87% | 34.79% | 76.45% | -32.98% |
| Prepaid Expenses | 345.37% | -8.03% | 209.27% | 388.50% | -11.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.74% | 46.56% | 40.49% | 30.85% | 41.10% |
|
|
|||||
| Total Current Assets | 11.74% | 46.56% | 40.49% | 30.85% | 41.10% |
| Net Property, Plant & Equipment | 770.00% | 658.72% | 280.91% | -18.98% | -8.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -11.87% | -11.53% | -11.22% | 113.96% | 114.65% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.18% | 4.94% | 83.34% | 86.68% | 333.64% |
| Total Assets | 16.05% | 49.12% | 42.06% | 31.35% | 43.37% |
|
|
|||||
| Total Accounts Payable | -14.98% | 73.98% | 51.56% | 5.34% | 48.28% |
| Total Accrued Expenses | 14.07% | 40.41% | 27.09% | 96.71% | 115.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -87.32% | -47.60% | -34.36% |
| Total Finance Division Other Current Liabilities | 137.07% | 79.68% | 148.24% | 185.53% | 166.71% |
| Total Other Current Liabilities | 137.07% | 79.68% | 148.24% | 185.53% | 166.71% |
| Total Current Liabilities | 66.27% | 68.33% | 77.70% | 75.01% | 102.94% |
|
|
|||||
| Total Current Liabilities | 66.27% | 68.33% | 77.70% | 75.01% | 102.94% |
| Long-Term Debt | 0.85% | 0.83% | 0.80% | 0.77% | 140.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 718.39% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 46.68% | 43.47% | 43.70% | 30.32% | 113.71% |
|
|
|||||
| Common Stock & APIC | 7.58% | 31.67% | 31.14% | 30.41% | 30.96% |
| Retained Earnings | -12.53% | -18.44% | -24.08% | -29.33% | -37.43% |
| Treasury Stock & Other | -450.59% | 112.85% | -16.47% | 122.16% | 234.92% |
| Total Common Equity | 1.90% | 52.95% | 41.10% | 31.86% | 24.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.90% | 52.95% | 41.10% | 31.86% | 24.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.90% | 52.95% | 41.10% | 31.86% | 24.43% |
|
|
|||||